64 filings
Page 2 of 4
8-K
r36n6v0r s29r0egp9ph
5 Sep 23
Regulation FD Disclosure
5:23pm
S-8
mdbe1pd4gjuv4ne pzn3
11 Aug 23
Registration of securities for employees
8:25am
8-K
bu6bsbmooztti0e tmyc
11 Aug 23
Acrivon Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
7:17am
8-K
7srhvu
22 Jun 23
Submission of Matters to a Vote of Security Holders
5:02pm
8-K
9nd8ejjcobl1
5 Jun 23
Entry into a Material Definitive Agreement
5:01pm
DEFR14A
klg80ub08 got
30 May 23
Revised proxy
4:23pm
8-K
3ti2x6vg
9 May 23
Acrivon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
8:13am
ARS
880o95 1yxud68pmj
1 May 23
Annual report to shareholders
4:29pm
DEFA14A
oqhcb01bdilmjcfs
1 May 23
Additional proxy soliciting materials
4:25pm
DEF 14A
jeywl78s1lr1uc5wh
1 May 23
Definitive proxy
4:23pm
8-K
xgakbp2 m054ssp3yar0
1 May 23
Regulation FD Disclosure
12:25pm
8-K
2bf1mgpv6v 79ymjwwzw
1 May 23
Results of Operations and Financial Condition
8:42am
8-K
yqzfblxr2p7qq8g 4j5
25 Apr 23
Regulation FD Disclosure
11:27am
S-8
e0m d5q1qd
29 Mar 23
Registration of securities for employees
8:21am
10-K
hac3pukeofhe
28 Mar 23
Annual report
4:45pm
8-K
ujle05 99c7h8u
28 Mar 23
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2022
8:06am
8-K
p49inzh
13 Mar 23
Results of Operations and Financial Condition
8:51am
8-K
nqlbra ynyh4pfy3
3 Mar 23
Other Events
5:08pm